Mynd.ai, Inc. - Depositary Receipt (Common Stock)
US ˙ NYSEAM

Introduction

This page provides a comprehensive analysis of the known insider trading history of Harris Geoffrey E.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Harris Geoffrey E. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:VYNT / Vyant Bio, Inc. Director 19,761
US:US87946W2026 / TELEMYND INC Director 97,110
US:MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Director 97,110
US:ANCI / Director 20,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Harris Geoffrey E.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-12-06 MYND Harris Geoffrey E. 1,000 3.8500 143 26.9500 3,850 730
2017-12-06 MYND Harris Geoffrey E. 3,500 3.8000 500 26.6000 13,300
2017-12-05 MYND Harris Geoffrey E. 52 3.6000 7 25.2000 187

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Insider Trades
Insider Sales MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MYND / Mynd.ai, Inc. - Depositary Receipt (Common Stock) Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Harris Geoffrey E. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2023-01-19 2023-01-17 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 5,712 19,761 40.66
2022-11-22 2022-11-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
S - Sale -666 14,019 -4.54 1.33 -888 18,701
2022-11-22 2022-11-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
S - Sale -99 14,685 -0.67 1.34 -133 19,679
2022-10-19 2022-10-17 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 10,841 73,920 17.19
2022-07-29 2022-07-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 6,141 63,079 10.79
2022-04-19 2022-04-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 5,157 56,938 9.96
2022-04-01 2022-03-30 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 43,478 51,781 523.64
2022-01-20 2022-01-18 4 VYNT Vyant Bio, Inc.
Common Stock, $0.0001 par value
A - Award 4,055 8,303 95.46 1.31 5,312 10,877
2021-04-01 2021-03-30 4 VYNT Vyant Bio, Inc.
Stock option (right to buy)
A - Award 13,015 13,015
2019-08-19 2019-07-23 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 100,000 100,000
2019-07-18 2019-07-16 4 NONE Telemynd, Inc.
Common Stock
J - Other 97,110 97,110
2019-01-16 2019-01-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 100,000 127,500 363.64 0.22 22,500 28,688
2018-10-10 2018-10-08 4 MYND MYnd Analytics, Inc.
COMMON STOCK
A - Award 45,000 97,110 86.36 1.38 62,100 134,012
2017-12-07 2017-12-06 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 3,500 52,110 7.20 3.80 13,300 198,018
2017-12-07 2017-12-06 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 1,000 48,610 2.10 3.85 3,850 187,148
2017-12-07 2017-12-05 4 MYND MYnd Analytics, Inc.
Common Stock
P - Purchase 52 47,610 0.11 3.60 187 171,396
2017-10-02 2017-09-28 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 5,000 5,000
2017-10-02 2017-09-28 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 27,500 10.00
2017-09-21 2017-09-19 4 MYND MYnd Analytics, Inc.
Director Stock Option (right to buy)
A - Award 18,000 18,000
2017-09-21 2017-09-19 4 MYND MYnd Analytics, Inc.
Common Stock
A - Award 18,000 47,558 60.90
2017-06-08 2017-06-07 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2017-06-08 2017-06-07 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 25,000 11.11
2017-05-16 2017-05-16 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 2,500 22,500 12.50 3.75 9,375 84,375
2017-03-03 2017-03-03 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 5,000 29,558 20.36 6.25 31,250 184,738
2016-12-14 2016-12-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 2,500 20,000 14.29 1.50 3,750 30,000
2016-11-16 2016-11-14 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
P - Purchase 5,000 17,500 40.00 1.55 7,750 27,125
2016-11-02 2016-11-01 4 MYAN MYnd Analytics, Inc.
Common Stock
A - Award 20,000 24,558 438.79
2016-10-13 2016-10-11 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2016-10-13 2016-10-11 4 CGIX CANCER GENETICS, INC
Common Stock, par value $0.0001 per share
A - Award 2,500 12,500 25.00
2016-09-23 2016-09-21 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
D - Sale to Issuer 0
2016-09-23 2016-09-21 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
M - Exercise
2016-09-23 2016-09-21 4 CNSO MYnd Analytics, Inc.
Common Stock
M - Exercise 2,058 4,558 82.32 5.00 10,290 22,790
2016-04-07 2016-04-05 4 CNSO MYnd Analytics, Inc.
Common Stock
A - Award 500,000 500,000
2016-02-25 2016-02-23 4 CNSO MYnd Analytics, Inc.
5% Secured Convertible Note due December 2017
A - Award 200,000
2016-02-25 2016-02-23 4 CNSO MYnd Analytics, Inc.
Common Stock Warrant
A - Award 200,000 200,000
2015-09-01 2015-08-28 4 ANCI American CareSource Holdings, Inc.
Common Stock
A - Award 10,000 20,000 100.00
2015-08-24 2015-08-20 4 CNSO CNS RESPONSE, INC.
Option to Purchase
A - Award 250,000 250,000
2015-05-18 2015-05-14 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 10,000 10,000
2015-05-18 2015-05-14 4 CGIX CANCER GENETICS, INC
Common Stock
A - Award 5,000 10,000 100.00
2015-05-18 2015-05-14 4 CGIX CANCER GENETICS, INC
Common Stock
P - Purchase 5,000 5,000 10.79 53,949 53,949
2014-12-15 2014-12-11 4 CGIX CANCER GENETICS, INC
Stock Option (right to buy)
A - Award 5,000 5,000
2014-06-26 2014-06-24 4 ANCI American Caresource Holdings, Inc.
Common Stock
A - Award 10,000 10,000
2014-06-26 3 ANCI American Caresource Holdings, Inc.
No securities are beneficially owned
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)